Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108895123 | 10889512 | 3 | F | 20160912 | 20150305 | 20160917 | EXP | PHEH2015US004177 | NOVARTIS | 0.00 | F | Y | 81.63000 | KG | 20160918 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108895123 | 10889512 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, QD | 22527 | .5 | MG | CAPSULE | QD | ||||||
| 108895123 | 10889512 | 2 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | U | 0 | ||||||||||
| 108895123 | 10889512 | 3 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 108895123 | 10889512 | 4 | C | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 108895123 | 10889512 | 5 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Unknown | U | 0 | ||||||||||
| 108895123 | 10889512 | 6 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108895123 | 10889512 | 1 | Multiple sclerosis |
| 108895123 | 10889512 | 2 | Product used for unknown indication |
| 108895123 | 10889512 | 3 | Product used for unknown indication |
| 108895123 | 10889512 | 4 | Product used for unknown indication |
| 108895123 | 10889512 | 5 | Product used for unknown indication |
| 108895123 | 10889512 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108895123 | 10889512 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108895123 | 10889512 | Ankle fracture | |
| 108895123 | 10889512 | Fall | |
| 108895123 | 10889512 | Gait disturbance | |
| 108895123 | 10889512 | Hyperreflexia | |
| 108895123 | 10889512 | Joint swelling | |
| 108895123 | 10889512 | Muscle spasticity | |
| 108895123 | 10889512 | Muscular weakness | |
| 108895123 | 10889512 | Sensory loss | |
| 108895123 | 10889512 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108895123 | 10889512 | 1 | 20130626 | 0 |